STAT3 天
Vertex’s upcoming sciatica trial readout is a high-stakes moment in its quest to quell pain
VertexPharma wants to transform the treatment of pain. An upcoming sciatica clinical trial readout will be pivotal.
India Education Diary5 天
Moscow Researchers Develop Russia’s Pioneer Lumbosacral Spine Phantom for Anesthesia ...
Scientists in Moscow have successfully developed Russia’s first lumbar spine phantom. This model will enable ...
Vertex Pharmaceuticals price target raised to $476 from $473 at Morgan Stanley
Morgan Stanley analyst Terence Flynn raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $476 from $473 and keeps an Equal ...
Medscape24 天
Tramadol in the Treatment of Neuropathic Cancer Pain
Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics ...